This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Galecto Biotech Ab. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Vishal Rajput: Innovator in Galectin Inhibition
Introduction
Vishal Rajput is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit galectins. His work is crucial for advancing treatments for various disorders related to galectin binding.
Latest Patents
Rajput holds a patent for "Galectoside inhibitors of galectins." This invention relates to novel compounds derived from readily accessible 3-O-propargyl-D-galactopyranoside derivatives. These compounds serve as galectin inhibitors, specifically targeting galectin-3. The patent outlines their potential use as a medicament for treating disorders associated with galectin binding to ligands in mammals.
Career Highlights
Vishal Rajput is currently associated with Galecto Biotech AB, where he continues to innovate in the field of galectin research. His work has the potential to impact therapeutic strategies significantly. With a focus on developing effective treatments, Rajput's contributions are paving the way for advancements in medical science.
Collaborations
Rajput collaborates with esteemed colleagues such as Ulf Nilsson and Hakon Leffler. Their combined expertise enhances the research and development efforts at Galecto Biotech AB.
Conclusion
Vishal Rajput is a pioneering inventor whose work on galectin inhibitors is making strides in medicinal chemistry. His innovative approach and dedication to research are vital for the future of therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile